^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    atuveciclib (BAY 1143572)

    i
    Associations
    News

    Trials

    Company:
    Bayer
    Drug class:
    CDK9 inhibitor, P-TEFb inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer (NCT01938638)
    Phase 1
    Bayer
    Completed
    Last update posted :
    10/20/2017
    Initiation :
    09/26/2013
    Primary completion :
    08/17/2016
    Completion :
    09/19/2016
    MYC • PCNA
    |
    MYC expression • PCNA expression
    |
    atuveciclib (BAY 1143572)